Stem cell and CRISPR/Cas9 gene editing technology in Alzheimer’s disease therapy: from basic research to clinical innovation

Stem cell and CRISPR/Cas9 gene editing technology in Alzheimer’s disease therapy: from basic research to clinical innovation

Alzheimer’s disease (AD), a progressive neurodegenerative disorder characterized by Aβ plaques, tau protein neuronal fiber tangles, and neuroinflammation, poses a significant global health problem, and current therapies focus on the symptoms rather than the cause. This paper gives a new multidimensi...

Full description

Saved in:
Bibliographic Details
Main Authors: Cong He, Baojiang Chen, Ciai Yan, Xiaoqing Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Genome Editing
Subjects:
Alzheimer’s disease
stem cell therapy
gene editing technology
neuroinflammation
personalized medical treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fgeed.2025.1612868/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items